CollPlant has opened a research and development center for 3D-bioprinting inks and dermal fillers. The company makes collagen from genetically engineered tobacco plants, and its products are approved in Europe for wound care and tendonitis treatment.
Company that makes collagen from tobacco plants scales up
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.